There is considerable evidence neurons that utilize the neuropeptide neurotensin (NT) are involved in both the mechanism of action of antipsychotic drugs (APDs) and the pathophysiology of schizophrenia. Despite this burgeoning database, there is no direct evidence to date that NT neurotransmission mediates behaviors relevant to the clinical efficacy of APDs. Conclusive demonstration of this association is the overall objective of this proposal. Hypotheses to be tested include the following; 1) Do all APDs increase NT release in the nucleus accumbens? 2) Is this increase in NT neurotransmission sufficient and necessary for the effects of APDs in behaviors relevant to clinical efficacy? 3) Are sex differences in schizophrenia related to ovarian hormone regulation of the NT system? 4) Are there specific alterations of the NT system in postmortem tissue consistent with an involvement of this system in the pathophysiology of schizophrenia? Thus, specific aim #1 scrutinizes the role of NT neurotransmission in animal models predictive of the clinical efficacy of APDs.
Specific aim #2 evaluates the putative involvement of NT neurotransmission in the therapeutically relevant behavioral effects of chronically administered APDs. Two behavioral paradigms (latent inhibition and prepulse inhibition (PPI) of the acoustic startle reflex) with face, predictive and construct validity as animal models of sensorimotor gating in schizophrenia will be utilized.
Specific aim #3 examines the behavioral consequence (specifically on sensorimotor gating ) of deficient NT neurotransmission in transgenic mice lacking NT.
Specific aim #4 would correlate ovarian hormone regulation of NT neurotransmission (including NT gene expression, NT release, and the electrophysiologic responsiveness of nucleus accumbens neurons to NT) with estrous cycle regulation of sensorimotor gating.
Specific aim # 5 explores a novel mechanism by which NT may directly modulate the D2 dopamine receptor.
Specific aim #6 continues examination of NT neuronal systems in postmortem brain tissue from patients with schizophrenia, bipolar depression, or normal controls, with focus given to brain regions implicated in sensorimotor gating. This linkage of studies is intended to provide the first definitive evidence that intact NT neurotransmission is critically involved in behaviors relevant to the clinical efficacy of APDs, and provide clear rationale for the use of NT agonists as novel APDs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH039415-17
Application #
6200316
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (03))
Program Officer
Winsky, Lois M
Project Start
1983-12-01
Project End
2005-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
17
Fiscal Year
2000
Total Cost
$339,570
Indirect Cost
Name
Emory University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chastain, Lucy G; Qu, Hongyan; Bourke, Chase H et al. (2015) Striatal dopamine receptor plasticity in neurotensin deficient mice. Behav Brain Res 280:160-71
Cáceda, Ricardo; Binder, Elisabeth B; Kinkead, Becky et al. (2012) The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion. Schizophr Res 136:88-95
Flandreau, Elizabeth I; Ressler, Kerry J; Owens, Michael J et al. (2012) Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 37:27-38
Pariante, Carmine M; Nemeroff, Charles B (2012) Unipolar depression. Handb Clin Neurol 106:239-49
Martin, Elizabeth I; Ressler, Kerry J; Jasnow, Aaron M et al. (2010) A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry 67:1212-6
Gatt, Justine M; Williams, Leanne M; Schofield, Peter R et al. (2010) Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety 27:752-9
Gatt, Justine M; Nemeroff, Charles B; Schofield, Peter R et al. (2010) Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 68:818-24
Zeng, Fanxing; Mun, Jiyoung; Jarkas, Nachwa et al. (2009) Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter. J Med Chem 52:62-73
Stein, Dan J; Cloitre, Marylene; Nemeroff, Charles B et al. (2009) Cape Town consensus on posttraumatic stress disorder. CNS Spectr 14:52-8
Neigh, Gretchen N; Gillespie, Charles F; Nemeroff, Charles B (2009) The neurobiological toll of child abuse and neglect. Trauma Violence Abuse 10:389-410

Showing the most recent 10 out of 113 publications